Physician profile
Thomas W Vertrees
NPI 1083862064
$2,875.00
in general payments reported to CMS, 2019-2025
16 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $173 · 2021: $305 · 2022: $382 · 2023: $655 · 2024: $391 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $922.57 | 2022-2025 | Dyanavel Xr, Onyda Xr, Quillichew Er |
| Ironshore Pharmaceuticals INC. | $550.27 | 2020-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $456.07 | 2021-2024 | Qelbree, Qelbree |
| Sunovion Pharmaceuticals INC. | $395.90 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $134.62 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $121.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $77.08 | 2020-2025 | Relexxii |
| Collegium Pharmaceutical, INC. | $62.14 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $35.56 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.51 | 2019 | |
| Corium, LLC | $22.16 | 2025 | Azstarys |
| Axsome Therapeutics, INC. | $16.66 | 2024 | Auvelity |
| Adlon Therapeutics L.P. | $14.73 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.54 | 2024 | Caplyta |
| Lundbeck LLC | $13.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Vertrees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.